当前位置：首页 > 文献互助 > 互助详情

Highly efficient and green micro/nano cellulose preparation with micro-nano bubbles from mild alkali pretreated bagasse复制

用户_wCeI6CHiX7g 1个月前 75 10 已完结

1. 系统已在2026-03-23 15:51:31对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1007/s10570-023-05457-5复制

文献链接: https://webofscience.clarivate.cn/wos/woscc/full-record/WOS:001064663800001复制

其他信息:

期刊名：Cellulose、南京工业大学、作者：Qian, Y、Ping, TT 、 Huang, H

上一篇：Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer

下一篇：Selective Host–Guest Interactions of a Transformable Coordination Capsule/Tube with Fullerenes

互助时间线

2026-03-16 15:58:38 [完结求助]

楼主确认了未来的路应助的文件是正确的, 求助状态变成 已完结

2026-03-16 15:51:31 [上传文件]

未来的路上传了文件(pdf 1.48 MB), 求助状态变成 待确认

2026-03-16 15:51:26 [发起求助]

最新发布的求助

Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors 34分钟前
Design and Synthesis of USP1 Inhibitors: Synergistic Antitumor Activity with PARP Inhibitors in Triple-Negative Breast Cancer 1小时前
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders 1小时前
AutoLead: An LLM-Guided Bayesian Optimization Framework for Multi-Objective Lead Optimization 1小时前
Voltage-Gated Sodium Channels in Pain: Which Channels, Which Blockers, and Where NaV1.7 Fits 3小时前
Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC) 5小时前
Rhabdomyosarcoma spheroids with central proliferation and differentiation 5小时前
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial 5小时前
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort 5小时前
Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs 5小时前
BPI26-027: Multidisciplinary Practice Patterns in HER2-Mutant NSCLC: Insights to Inform Precision Oncology Education 5小时前
ERBB2 activating mutations and co-occurring genomic alterations contribute to disease heterogeneity in patients with ERBB2-mutant lung cancer 5小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com